Tech Company Financing Transactions
OneCell Diagnostics Funding Round
OneCell Diagnostics closed a $16 million Series A funding round on 11/21/2024. Investors included Celesta Capital, Cedars-Sinai Medical Center and Singularity Ventures.
Transaction Overview
Company Name
Announced On
11/21/2024
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series A
Investors
Celesta Capital (Lead Investor) (Michael Marks)
Proceeds Purpose
The funding will be used to advance its vision of democratizing precision oncology through cancer diagnostic testing that is more accessible, actionable, and affordable.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
20380 Town Center Lane 218
Cupertino, CA 95014
USA
Cupertino, CA 95014
USA
Phone
Undisclosed
Website
Email Address
Overview
Providing comprehensive genomic solutions for better cancer management leveraging cutting-edge Next-Generation Sequencing technology (NGS) in combination with strong bioinformatics, AI / ML and data-analytics for multi-omics biomarkers. Vision: Democratizing precision oncology, by making it actionable, accessible and affordable. Mission: Impacting lives of one million cancer patients by breakthrough innovations in science and AI technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mohan Uttarwar
Chief Medical Officer
Gowhar Shafi
Chief Operating Officer
Aravindan Vasudevan
Chief Scientific Officer
Jayant Khandare
VP - Bus. Development
Surinnder Dang
Browse more venture capital transactions:
Prev: 11/21/2024: Enveda venture capital transaction
Next: 11/21/2024: Iontra venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs